InvestorsObserver is giving ENDRA Life Sciences Inc (NDRA) an Analyst Rating Rank of 74, meaning NDRA is ranked higher by analysts than 74% of stocks. The average price target for NDRA is $6 and analyst’s rate the stock as a Strong Buy.
Wall Street analysts are rating NDRA a Strong Buy today. Find out what this means to you and get the rest of the rankings on NDRA!
Fundamental research of the underlying health of a company can be an extremely useful resource when making investment decisions. Analysts observe growth prospects and forecasted earnings of companies to gain a comprehensive view of particular industries. This data allows traders to react before numbers are officially reported.
InvestorsObserver takes the ratings from these analysts and percentile ranks those aveages. This allows you to compare stocks extensively and in more detail than the common buy/hold/sell ratings.
What's Happening With ENDRA Life Sciences Inc Stock Today?
ENDRA Life Sciences Inc (NDRA) stock is down -4.9% while the S&P 500 is up 0.77% as of 9:58 AM on Monday, Nov 22. NDRA is lower by -$0.05 from the previous closing price of $1.02 on volume of 109,033 shares. Over the past year the S&P 500 has risen 32.33% while NDRA is up 21.25%. NDRA lost -$0.62 per share the over the last 12 months.
Click Here to get the full Stock Report for ENDRA Life Sciences Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
